What companies are JAZZ's competitors?

Jazz Pharmaceuticals plc (JAZZ)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does JAZZ compare to its peers?

The peer comparison table on this page shows Jazz Pharmaceuticals plc (JAZZ) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does JAZZ operate in?

Jazz Pharmaceuticals plc (JAZZ) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

JAZZ

Jazz Pharmaceuticals plc

NASDAQ·Biotechnology · Healthcare

$240.07$6.74−2.73%

Pre-market·$240.67+0.25%

Market cap$15.08B·Market closed·Sep 8 8:00 PM UTC

Frequently Asked Questions About JAZZ

What companies are JAZZ's competitors?: Jazz Pharmaceuticals plc (JAZZ)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does JAZZ compare to its peers?: The peer comparison table on this page shows Jazz Pharmaceuticals plc (JAZZ) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does JAZZ operate in?: Jazz Pharmaceuticals plc (JAZZ) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

JAZZ

Jazz Pharmaceuticals plc

NASDAQ·Biotechnology · Healthcare

$240.07$6.74−2.73%

Pre-market·$240.67+0.25%

Market cap$15.08B·Market closed·Sep 8 8:00 PM UTC

Peers


HALO	Halozyme Therapeutics, Inc.	$108.31	$12.8B
MDGL	Madrigal Pharmaceuticals, Inc.	$534.16	$12.3B
AXSM	Axsome Therapeutics, Inc.	$207.82	$10.7B
CYTK	Cytokinetics, Incorporated	$75.35	$9.4B
NUVL	Nuvalent, Inc.	$123.96	$9.1B
ABVX	Abivax S.A.	$118.95	$8.7B
CAI	Caris Life Sciences, Inc.	$24.82	$7.0B
RYTM	Rhythm Pharmaceuticals, Inc.	$101.80	$7.0B
MRUS	Merus N.V.	$90.00	$6.8B
RNA	Atrium Therapeutics, Inc.	$11.35	$194.1M

Frequently Asked Questions About JAZZ

What companies are JAZZ's competitors?: Jazz Pharmaceuticals plc (JAZZ)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does JAZZ compare to its peers?: The peer comparison table on this page shows Jazz Pharmaceuticals plc (JAZZ) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does JAZZ operate in?: Jazz Pharmaceuticals plc (JAZZ) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.